See What HealthDay Can Do For You
Contact Us

Psychedelic Research Center Created at Johns Hopkins University

Center has received $17 million in funding from group of private donors

technician working with laboratory specimen

THURSDAY, Sept. 5, 2019 (HealthDay News) -- A research center that will assess the use of psychedelic drugs to treat conditions such as addiction, alcoholism, and depression was announced by Johns Hopkins University.

"Johns Hopkins is deeply committed to exploring innovative treatments for our patients," Paul Rothman, M.D., dean of the medical faculty and CEO of Johns Hopkins Medicine, said in a statement, ABC News reported.

"Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential," Rothman added.

The center, which received $17 million in funding from a group of private donors, will also use psychedelic drugs to study the brain and behavior, ABC News reported.

ABC News Article

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.